Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.58
+11.50%
Mkt Cap $17.71M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+417.4%
Consensus $3.00 vs current $0.58
NASDAQ·Healthcare·Biotechnology
$0.58
+11.50%
Mkt Cap $17.71M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+417.4%
Consensus $3.00 vs current $0.58